Thank you, Mr. Chair.
Dr. Falcone, I am very pleased that you accepted our invitation. I hope that CIHR, or the Canadian Institutes of Health Research, will show as much innovation and research spirit as the Government of Quebec has done.
That said, I have nearly 15 questions to ask—we'll see what we can do in six minutes—which are divided into different categories. First, there are the risk factors, the effects of vaccination on long COVID, and the symptoms. Why do there seem to be more cases in women, for example? What about recovery and the effects of long COVID? There were fewer NAATs, or nucleic acid amplification tests. Is this related to the effects of long COVID? Anyway, I'll start.
Are there any particular risk factors that might accentuate the possibility of developing long COVID?
I am aware that in eight months you may not have been able to get all the answers to the questions I have today. Please feel free to tell me so.